Sex difference in coronavirus disease (COVID-19): a systematic review and meta-analysis

BB Abate, AM Kassie, MW Kassaw, TG Aragie… - BMJ open, 2020 - bmjopen.bmj.com
Objective To assess the sex difference in the prevalence of COVID-19 confirmed cases.
Design Systematic review and meta-analysis. Setting PubMed, Cochrane Library and …

The prevalence of multiple sclerosis in the world: an update

G Rosati - Neurological sciences, 2001 - Springer
The systematic study of multiple sclerosis (MS) in populations, started in 1929 by Sydney
Allison, now consists of over 400 publications dealing with the prevalence of MS throughout …

MS quality of life, depression, and fatigue improve after mindfulness training: a randomized trial

P Grossman, L Kappos, H Gensicke, M D'Souza… - Neurology, 2010 - AAN Enterprises
Objective: Health-related quality of life (HRQOL) is often much reduced among individuals
with multiple sclerosis (MS), and incidences of depression, fatigue, and anxiety are high. We …

Categorization of humans in biomedical research: genes, race and disease

N Risch, E Burchard, E Ziv, H Tang - Genome biology, 2002 - Springer
A debate has arisen regarding the validity of racial/ethnic categories for biomedical and
genetic research. Some claim'no biological basis for race'while others advocate a'race …

[PDF][PDF] Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans

JR Oksenberg, LF Barcellos, BAC Cree… - The American Journal of …, 2004 - cell.com
An underlying complex genetic susceptibility exists in multiple sclerosis (MS), and an
association with the HLA-DRB1* 1501-DQB1* 0602 haplotype has been repeatedly …

Non‐pharmacological interventions for chronic pain in multiple sclerosis

B Amatya, J Young, F Khan - Cochrane Database of …, 2018 - cochranelibrary.com
Background Chronic pain is common and significantly impacts on the lives of persons with
multiple sclerosis (pwMS). Various types of non‐pharmacological interventions are widely …

Prevalence of multiple sclerosis in Isfahan, Iran

M Etemadifar, M Janghorbani, V Shaygannejad… - …, 2006 - karger.com
Background: The prevalence of multiple sclerosis (MS) shows considerable variability all
over the world. According to Kurtzke, Iran is considered to have a low prevalence. Objective …

A pilot study of oral calcitriol (1, 25-dihydroxyvitamin D3) for relapsing–remitting multiple sclerosis

DM Wingerchuk, J Lesaux, GPA Rice… - Journal of Neurology …, 2005 - jnnp.bmj.com
Background: Epidemiological and ecological studies suggest links between vitamin D
deficiency and increased multiple sclerosis (MS) prevalence. Objective: To evaluate the …

Regional variations in the prevalence of multiple sclerosis in French farmers

S Vukusic, V Van Bockstael, S Gosselin… - Journal of Neurology …, 2007 - jnnp.bmj.com
Background: Studies on the prevalence of multiple sclerosis have been carried out
worldwide, showing a heterogeneous distribution between countries and even between the …

Genome‐wide association studies of multiple sclerosis

C Cotsapas, M Mitrovic - Clinical & translational immunology, 2018 - Wiley Online Library
Large‐scale genetic studies of multiple sclerosis have identified over 230 risk effects across
the human genome, making it a prototypical common disease with complex genetic …